Methods and compositions for deterring abuse
View Patent ↗Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse comprising at least 10% by weight hydroxypropylcellulose; polyethylene oxide; and a disintegrant selected from the group consisting of crospovidone, sodium starch glycolate and croscarmellose sodium; wherein the ratio of hydroxypropylcellulose to polyethylene oxide on a weight basis is between about 10:1 and 1:10.
1. A composition suitable for reducing the chemical conversion of precursor compounds included in the composition to a drug susceptible to abuse comprising:
pseudoephedrine, or a therapeutically acceptable salt thereof;
at least 10% by weight hydroxypropylcellulose;
polyethylene oxide; and
about 2% by weight to about 25% by weight of a disintegrant selected from the group consisting of crospovidone, sodium starch glycolate and croscarmellose sodium;
wherein the ratio of hydroxypropylcellulose to polyethylene oxide on a weight basis is between about 10:1 and 1:10.
2. The therapeutic composition of claim 1 , wherein the composition further comprises ethylcellulose.
3. The therapeutic composition of claim 2 , wherein the ethylcellulose includes ethoxyl in an amount of about 48.0% to about 49.5%.
4. The therapeutic composition of claim 2 , wherein the ethylcellulose includes ethoxyl in an amount of about 49.6% to about 52.5%.
5. The therapeutic composition of claim 2 , wherein the ethylcellulose includes ethoxyl in an amount of about 45.0% to about 47.9%.
6. The composition of claim 1 , wherein the hydroxypropylcellulose has a viscosity of about 1,500 mPa·s to about 3,000 mPa·s.
7. The composition of claim 1 , wherein the composition is an immediate release composition.